For more than twenty years, the Cologne native has been intensively involved with the stock market, both professionally and privately. He is particularly passionate about national and international small and micro caps.
He first came into contact with the stock market and shares during his banking apprenticeship. After completing this in 2000, he gained his first journalistic experience in the editorial department of a financial portal. During his subsequent studies in business administration, he also worked in the area of investor relations.
Since then, he has remained true to the capital markets and is excited to report on every newly discovered interesting story - as well as on long-standing success stories.
Commented by Fabian Lorenz
Commented by Fabian Lorenz on July 12th, 2023 | 07:20 CEST
Top news: Volkswagen with problems, Plug Power and dynaCERT profit
Is the electric motor stuttering at Volkswagen? Recent reports indicate that it is. Prices for the ID.3 have been massively reduced in China, and most recently, Handelsblatt reported on sales problems for the Wolfsburg-based company's electric models in Europe. In the hydrogen sector, however, the mood has improved considerably. BloombergNEF predicts significant economies of scale for the industry, and the successful IPO of ThyssenKrupp Nucera illustrates investor interest. Pure-play Plug Power and newcomer dynaCERT can also benefit from this. dynaCERT is convincing with a positive newsflow, and one customer believes in a revolution. Analysts see 30% share price potential for Plug Power.
Read
Commented by Fabian Lorenz on July 6th, 2023 | 07:00 CEST
Battery revolution in Germany: BYD, BASF, Altech Advanced Materials
Negative electricity prices? Last weekend, it happened again. In the meantime, 1 megawatt-hour of electricity costs minus EUR 500. It is a pity that there are no large-scale energy storage systems - YET. Altech Advanced Materials is working together with Fraunhofer IKTS on the next-generation battery, and it is "Made in Germany." The next milestone is due this year, and the FAZ sees room for improvement in the share price. Analysts see no room for improvement in BASF shares and recommend "sell". However, the DAX-listed company has just commissioned a battery factory, and demand is said to be high. BYD is also benefiting from high demand. Will the Chinese company soon be producing their e-cars in Germany?
Read
Commented by Fabian Lorenz on July 5th, 2023 | 07:10 CEST
New hydrogen hopes: Nel, ThyssenKrupp and First Hydrogen
Attention Nel and Plug Power shareholders! After numerous hydrogen pure-plays had massively disappointed in the past few years, it was hard to get past the two industry giants. But now new players are coming into focus, like ThyssenKrupp Nucera and First Hydrogen. The subscription period for the Nucera IPO ends today. The eagerly awaited initial listing will take place on Friday. Is the entry worthwhile? Excitement is also mounting at First Hydrogen. Tests of its hydrogen fuel cell commercial vehicles in the UK are going better than expected and could soon lead to larger orders. The Company is also working to build a hydrogen production facility. And what is Nel doing? While the stock is battered on the chart, analysts see more than 50% upside potential.
Read
Commented by Fabian Lorenz on June 29th, 2023 | 08:10 CEST
Change of favorites in hydrogen shares! ThyssenKrupp instead of Nel ASA? Can Grid Metals take off?
Is there a shift in favorites among hydrogen stocks? It certainly seems that way. While former favorites Nel ASA and Plug Power are struggling, ThyssenKrupp is making a strong entry with the IPO of Nucera. The subscription period for the hydrogen subsidiary has been running since Friday, and demand already exceeds supply. In contrast, Nel ASA and Plug Power are being left behind. The Danes, in particular, are facing technical chart challenges and are struggling to maintain the EUR 1 mark. But perhaps the hype around Nucera is an entry opportunity for the established hydrogen specialists. And what about lithium? Stocks such as Standard Lithium and Alkem have been trending nicely in recent weeks. Grid Metals has yet to gain momentum, despite plans to process lithium as early as 2024.
Read
Commented by Fabian Lorenz on June 28th, 2023 | 08:05 CEST
Hydrogen vs battery shares: From Plug Power to Standard Lithium and Power Nickel?
Who does the future belong to? Hydrogen or battery technology? The truth likely lies somewhere in the middle, and both technologies will find their place. However, it is clear that batteries currently have the upper hand in the context of electromobility. This can also be seen in the stock market. While companies like Nel ASA and Plug Power are struggling, Tesla, BYD & Co. are celebrating record sales. But success is heavily dependent on the supply of raw materials. Lithium and nickel are scarce and in high demand. Standard Lithium and Power Nickel are among the profiteers. Standard Lithium is recommended as a buy by analysts with around 100% price potential. Power Nickel has again published promising drill results, which could multiply the upcoming resource estimate. Plug Power is currently overshadowed by the Nucera IPO, but there is some interesting news.
Read
Commented by Fabian Lorenz on June 22nd, 2023 | 07:30 CEST
After Lanxess shock, now time to invest in gold? Barrick, Manuka Resources, Evonik
Now into gold shares? The recent profit warnings from the chemical sector should not be underestimated. After all, chemicals are an important early indicator of a possible recession. Lanxess recently shocked the stock market with a profit warning. Before that, the British specialty chemicals producer Croda, among others, had already issued a warning. Are BASF and Evonik the next spoilsports? Analysts are becoming increasingly sceptical, and share price targets are plummeting. A recession would catch many investors off guard. Therefore, gold shares are worth a look again. Heavyweight Barrick is ailing on the chart but remains a solid investment. Manuka Resources has an interesting story. Investors are in for an exciting few months.
Read
Commented by Fabian Lorenz on June 21st, 2023 | 08:40 CEST
Biotech comeback! Profit with BioNTech, Morphosys and BioNxt Solutions
Biotech shares have not been among the favourites on the stock market in recent months. After the Corona hype, they were overshadowed by BigTech and especially AI. Sartorius, BioNTech and Co. have corrected strongly. But in the meantime, there are strong signs of a comeback - led by Morphosys. The share of the German biotech veteran has doubled since the beginning of April. MediGene and Evotec have also recorded price jumps. Are BioNTech and BioNxt Solutions next? Morphosys also continues to be praised by analysts. But Goldman Sachs wants to end the party.
Read
Commented by Fabian Lorenz on June 15th, 2023 | 08:00 CEST
Plug Power share unstoppable! BYD and Globex Mining are on the rise!
Three shares along the energy transition value chain: Plug Power is currently unstoppable. Yesterday, the stock of the hydrogen pureplay again gained around 5%. On a one-month horizon, the gain is now around 50%. And it could go on because Plug Power had fresh orders in its luggage at yesterday's analyst day. The BYD share has also regained momentum in recent weeks. If it manages to jump above USD 33.50, the way is clear for the time being. Globex Mining is also worth a closer look. With this share, investors can add a broad commodity portfolio to their portfolio and thus benefit from the super cycle in a risk-reduced manner.
Read
Commented by Fabian Lorenz on June 14th, 2023 | 07:00 CEST
Evotec, Morphosys, Defence Therapeutics: Strong biotech stocks
When thinking of strong biotech stocks in recent years, BioNTech likely came to mind initially. With the successful development of the COVID-19 vaccine, the Mainz-based company advanced to become the new industry high-flyer. But in the meantime, the Company has come back to reality. The coffers are bulging, but vaccine revenues are falling, and the development of the cancer pipeline will still take several years. Therefore, Evotec and Morphosys are currently celebrating a comeback. Analysts are hailing Evotec as the "Tesla of biotech," and price targets are rising. The Morphosys share has increased by more than 100% this year, and analysts believe the value is capable of even more. Due to positive news, investors can speculate on a rebound with Defence Therapeutics.
Read
Commented by Fabian Lorenz on June 8th, 2023 | 07:45 CEST
ChatGPT and AI revolution reaches defence stocks: Palantir, Hensoldt, Star Navigation Systems
The euphoria around ChatGPT and artificial intelligence (AI) is currently electrifying companies and stockbrokers. Chip manufacturer Nvidia is the high flyer of the current year. But high-tech and AI also play an increasing role in the defence and armament sectors. Palantir is also benefiting from this. The share has jumped recently but is still far from its all-time high. The US military has struck again at the software company. But analysts are putting the brakes on the euphoria. Hot stock Star Navigation could soon take off. And MDAX group Hensoldt has taken a stake in an AI specialist and is working on new defence systems.
Read